Viela Bio, Inc.

NYSE
VIE
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Share chart Viela Bio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Viela Bio, Inc.

Viela Bio, Inc., биотехнологическая компания, работающая на клинической стадии, занимается исследованиями и разработкой методов лечения тяжелых воспалений и аутоиммунных заболеваний в США. Основным кандидатом на продукцию компании является инебилизумаб, гуманизированное моноклональное антитело для лечения расстройства оптического спектра нейромиелита, десенсибилизации трансплантата почки, миастении и заболеваний, связанных с IgG4. Также разрабатывается VIB4920 для лечения отторжения трансплантации почки и синдрома Шегрена; и VIB7734 для кожной красной волчанки. Viela Bio, Inc. осуществляет стратегическое сотрудничество с Mitsubishi Tanabe Pharma Corporation по разработке и коммерциализации инебилизумаба для лечения аутоиммунных заболеваний в Японии, Таиланде, Южной Корее, Индонезии, Вьетнаме, Малайзии, Филиппинах, Сингапуре и Тайване. Компания была основана в 2017 году, ее штаб-квартира находится в Гейтерсбурге, штат Мэриленд.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date
2019-10-03
ISIN
US9266131005
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
link
All parameters

Grade

Underestimation
Title Value Grade
P/S 249.99 1
P/BV 4.87 3
P/E 0 0
Efficiency
Title Value Grade
ROA -23.83 0
ROE -41.26 0
ROIC 0 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -0.0151 10
Debt/Ratio 0 10
Debt/Equity 0 10
Growth impulse
Title Value Grade
Yield Revenue, % -76.6 0
Yield Ebitda, % -260.38 0
Yield EPS, % -29.02 0
More

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 26.55 $ 0 $ 0 $ 0 % 0 % 0 %
Week 26.55 $ 0 $ 0 $ 0 % 0 % 0 %
Month 26.55 $ 0 $ 0 $ 0 % 0 % 0 %
Three month 26.55 $ 26.55 $ 26.55 $ 0 % 0 % 0 %
Half a year 26.55 $ 26.55 $ 26.55 $ 0 % 0 % 0 %
Year 26.55 $ 26.55 $ 26.55 $ 0 % 0 % 0 %
3 years 26.55 $ 26.55 $ 26.55 $ 0 % 0 % 0 %
5 years 52.85 $ 21.5 $ 55.52 $ -49.76 % 0 % 0 %
10 years 18.75 $ 18.75 $ 60.21 $ +282.72 % 0 % 0 %
Year to date 26.55 $ 26.55 $ 26.55 $ 0 % 0 % 0 %

Main owners

Institutions Volume Share, %
Fidelity SelectCo, LLC 9 007 706 16.41
BlackRock Advisors (UK) Limited 7 432 955 1.1
DWS Investment S.A. 7 247 749 1.28
Amundi Asset Management 6 017 220 0.89
Invesco Asset Management Ltd 5 503 123 0.81
BNP Paribas Asset Management France 5 220 977 0.77
Moneta Asset Management 4 936 664 0.87
KBI Global Investors Ltd 4 921 798 0.73
Fidelity Management & Research Company LLC 4 232 414 7.71
Temasek Holdings Ltd. 4 070 330 7.41
La Banque Postale Asset Management 3 471 253 0.51
Allianz Global Investors GmbH 3 265 500 0.48
Fidelity Management & Research Company LLC 3 051 675 5.56
Templeton Investment Counsel LLC 2 815 282 0.5
Invesco Capital Management LLC 2 787 289 0.41
HSBC Global Asset Management (France) 2 420 928 0.36
Hillhouse Capital Advisors, Ltd. 2 382 414 4.34
Sycomore Asset Management 2 358 168 0.42
DNCA Finance 2 070 214 0.31
Covéa Finance 1 795 800 0.27
HBM Partners Cayman Ltd 1 750 000 3.19
Cormorant Asset Management, LLC 1 585 000 2.89
BlackRock Fund Advisors 1 409 027 2.57
Rothschild & Co Asset Management Europe 1 156 889 0.17
Eurizon AM SGR S.p.A. 1 088 005 0.16
Clartan Associés 1 078 191 0.16
Caixabank Asset Management SGIIC 1 025 742 0.15
Crédit Mutuel Asset Management 1 014 781 0.15
Alken Asset Management LLP 853 101 0.15
Dorval Asset Management 844 607 0.15
SSGA Funds Management Inc 738 568 1.35
Federal Finance Gestion 683 442 0.1
American Century Investment Management, Inc 558 048 1.02
iM Global Partner Asset Management S.A. 549 827 0.1
Fidelity Investments 411 458 0.75
Northern Trust Investments Inc 381 180 0.69
Universal-Investment GmbH 269 928 0.04
Meeschaert Asset Management 230 639 0.03
State Street Global Advisors 225 554 0.41
Palatine Asset Management 222 674 0.04
Equitable 162 264 0.3
The Variable Annuity Life Insurance Company 73 540 0.13
Federated MDTA LLC 58 421 0.11
Fidelity Investments Canada ULC 54 767 0.1
JPMorgan Chase Bank 47 333 0.09
SEI Investments Management Corp 40 360 0.07
Pinz Capital Management, LP 31 150 0.06
Principal Global Investors, LLC 19 368 0.04
SunAmerica Asset Management, LLC 16 285 0.03
ETFS Management (AUS) Ltd 2 886 0.01
AlphaCentric Advisors LLC 1 500 0
Defiance ETFs, LLC 1 245 0
PGIM Investments LLC 1 099 0
Pharus Asset Management SA 950 0
E Fund Mgmt Co.,Ltd 715 0
Invesco Capital Markets Inc 62 0

Contained in ETF

ETF Share, % Profitability for 1 year, % Commission, %
Ecofin Global Water ESG Fund 7.47285 4.01 0.40
Goldman Sachs Future Real Estate and Infrastructure Equity ETF 1.16458 -10.41 0.75
VictoryShares International High Div Volatility Wtd ETF 1.11003 -2.7 0.45
Nuveen Global Net Zero Transition ETF 1.00034 0.9191 0.56
IQ 500 International ETF 0.31401 -6.17 0.25
VictoryShares Developed Enhanced Volatility Wtd ETF 0.25156 1902.8 0.51

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Zhengbin Yao Chairman, Pres & CEO 1966 (59 years)
Mr. Mitchell Chan Chief Financial Officer 1981 (44 years)
Dr. Jörn Drappa M.D., Ph.D. Chief Medical Officer and Head of R&D 1965 (60 years)
Mr. James Paul Kastenmayer J.D., Ph.D. Gen. Counsel & Company Sec. 1972 (53 years)
Ms. Kate Surdez Sr. VP & Head of HR
Ms. Rachel Ettinger Sr. Director & Head of Research
Mr. Bill Rees Sr. Director & Head of Translational Science
Mr. Ted Phillips VP & Head of Clinical Operations
Mr. Dewei She Sr. Director and Head of Biostatistics, Data Management, & Programming
Mr. Lee Levin Sr. Director & Head of Quality

About company

Address: United States, Gaithersburg, One MedImmune Way - Open in google maps, Open in yandex maps
Website: http://www.vielabio.com